Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares IssuedShares OutstandingShares Outstanding
Ratios

Vaxcyte (PCVX) Shares Issued (2019 - 2026)

Vaxcyte (PCVX) has 8 years of Shares Issued data on record, last reported at $9.0 million in Q1 2026.

  • On a quarterly basis, Shares Issued rose 49.31% to $9.0 million in Q1 2026 year-over-year; TTM through Mar 2026 was $16.0 million, a 43.24% decrease, with the full-year FY2025 number at $13.0 million, down 52.09% from a year prior.
  • Shares Issued reached $9.0 million in Q1 2026 per PCVX's latest filing, up from $3.4 million in the prior quarter.
  • Over the last five years, Shares Issued for PCVX hit a ceiling of $51.8 million in Q2 2022 and a floor of -$89.3 million in Q4 2022.
  • A 5-year average of $3.7 million and a median of $4.4 million in 2024 define the central range for Shares Issued.
  • Peak YoY movement for Shares Issued: crashed 1335.85% in 2022, then skyrocketed 14718.09% in 2023.
  • Tracing PCVX's Shares Issued over 5 years: stood at -$89.3 million in 2022, then skyrocketed by 104.6% to $4.1 million in 2023, then skyrocketed by 45.77% to $6.0 million in 2024, then crashed by 42.93% to $3.4 million in 2025, then skyrocketed by 164.48% to $9.0 million in 2026.
  • Business Quant data shows Shares Issued for PCVX at $9.0 million in Q1 2026, $3.4 million in Q4 2025, and $306000.0 in Q3 2025.